206 filings
Page 2 of 11
8-K
0nkn0o8 16mqqj
1 Jul 19
Departure of Directors or Certain Officers
4:33pm
8-K
wmjosg08dn93 n9fnr
19 Jun 19
Other Events
5:00pm
8-K
912v72f672xv5ua81cy3
15 Apr 19
W. Mark Watson Elected as Chairman of the Board
5:30pm
8-K
hjio5j 31
13 Feb 19
Regulation FD Disclosure
4:31pm
8-K
w6kpbd4z5hr99ngavmjz
31 Dec 18
Entry into a Material Definitive Agreement
5:16pm
8-K
zfk1n7
17 Dec 18
Enter into Updated Collaboration and Funding Agreements
5:15pm
8-K
czdkq61kn4z 8szje7
5 Nov 18
Regulation FD Disclosure
4:49pm
8-K
213 77x8i
10 Jul 18
HedgePath Pharmaceuticals Closes Second Tranche of Mayne Pharma Financing
4:31pm
8-K
ef4soi4p44g7 wlo8f
11 Jan 18
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs
12:00am
8-K
5lnifkw1 rxmswf4c
20 Dec 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5kr7r y2r2cc
5 Oct 17
Other Events
12:00am
8-K
yrw46hhwt5nuhe9pv
27 Jul 17
HedgePath Pharmaceuticals Receives Clarity From FDA Regarding
12:00am
8-K
c1bgf6s
30 May 17
HedgePath Pharmaceuticals Announces Granting of
12:00am
8-K
tu7w 0nze2domygc84
24 Jan 17
Regulation FD Disclosure
12:00am
8-K
civ157qyrjest9xtudf
2 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
ja1 d882nsh2u00skx
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
dkea4smh1owte1qjngm
8 Nov 16
Changes in Control of Registrant
12:00am
8-K
dwfp8t
1 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
kgfqb
26 May 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
nyr06c cv
3 May 16
Entry into a Material Definitive Agreement
12:00am